An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

Great news!Our paper "Data infrastructures for AI in medical imaging: a report on the experiences of five EU projects" published in European Radiology Experimental, has been the Fourth most cited article for the Impact Factor 2024 calculation. A short award ceremony...

  An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging...

Prostate cancer is the second most commonly diagnosed cancer in men. Conventional screening relies on prostate specific antigen (PSA) levels in the blood, which can indicate prostate abnormalities but lacks specificity. Clinical examination and ultrasound also have...

The ProCAncer-I project aims to revolutionize prostate cancer diagnosis and treatment through the power of artificial intelligence and advanced imaging. By creating a large, federated database of prostate MRI scans and clinical data, the project enables the...